Irland - engelsk - HPRA (Health Products Regulatory Authority)

athlone laboratories ltd - paracetamol; tramadol hydrochloride - film-coated tablet - 37.5/325 milligram(s) - other opioids; tramadol, combinations

Irland - engelsk - HPRA (Health Products Regulatory Authority)

athlone pharmaceuticals limited - tramadol hydrochloride; paracetamol - film-coated tablet - other opioids; tramadol, combinations

Irland - engelsk - HPRA (Health Products Regulatory Authority)

amneal pharma europe limited - tramadol hydrochloride; paracetamol - film-coated tablet - 37.5/325 milligram(s) - other opioids; tramadol, combinations

Irland - engelsk - HPRA (Health Products Regulatory Authority)

generics (uk) limited - tramadol hydrochloride; paracetamol 90% dcl (compap l) - film-coated tablet - 37.5/325 milligram(s) - opioids in combination with non-opioid analgesics; opiods in combination with non-opiod analgesics

Irland - engelsk - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd., t/a gerard laboratories - tramadol hydrochloride; paracetamol - film-coated tablet - 37.5 mg/325 milligram(s) - opioids in combination with non-opioid analgesics; opiods in combination with non-opiod analgesics

Polen - polsk - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

accord healthcare polska sp. z o.o. - tramadoli hydrochloridum + paracetamolum - tabletki musujące - 37,5 mg + 325 mg

Nederland - nederlandsk - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

amneal pharma europe limited 70 sir john rogerson's quay dublin 2 (ierland) - paracetamol ; tramadolhydrochloride samenstelling overeenkomend met ; tramadol - filmomhulde tablet - carnaubawas (e 903) ; cellulose, microkristallijn (e 460) ; crospovidon (e 1202) ; hypromellose, type 2910 (3 - 15 mpa.s) (e 464) ; ijzeroxide geel (e 172) ; macrogol 400 ; maÏszetmeel, gepregelatineerd ; natriumzetmeelglycolaat ; polysorbaat 80 (e 433) ; povidon k 30 (e 1201) ; siliciumdioxide (e 551) ; stearinezuur (e 570) ; titaandioxide (e 171), carnaubawas (e 903) ; cellulose, microkristallijn (e 460) ; crospovidon (e 1202) ; hypromellose, type 2910 (3 - 15 mpa.s) (e 464) ; ijzeroxide geel (e 172) ; macrogol 400 ; maÏszetmeel, gepregelatineerd ; natriumzetmeelglycolaat (e468) ; polysorbaat 80 (e 433) ; povidon k 30 (e 1201) ; siliciumdioxide (e 551) ; stearinezuur (e 570) ; titaandioxide (e 171) - tramadol and paracetamol

Nederland - nederlandsk - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

amneal pharma europe limited - paracetamol ; tramadolhydrochloride samenstelling overeenkomend met ; tramadol - filmomhulde tablet - carnaubawas (e 903) ; cellulose, microkristallijn (e 460) ; crospovidon (e 1202) ; hypromellose, type 2910 (3 - 15 mpa.s) (e 464) ; ijzeroxide geel (e 172) ; macrogol 400 ; maÏszetmeel, gepregelatineerd ; natriumzetmeelglycolaat ; polysorbaat 80 (e 433) ; povidon k 30 (e 1201) ; siliciumdioxide (e 551) ; stearinezuur (e 570) ; titaandioxide (e 171), carnaubawas (e 903) ; cellulose, microkristallijn (e 460) ; crospovidon (e 1202) ; hypromellose, type 2910 (3 - 15 mpa.s) (e 464) ; ijzeroxide geel (e 172) ; macrogol 400 ; maÏszetmeel, gepregelatineerd ; natriumzetmeelglycolaat (e468) ; polysorbaat 80 (e 433) ; povidon k 30 (e 1201) ; siliciumdioxide (e 551) ; stearinezuur (e 570) ; titaandioxide (e 171) - tramadol and paracetamol

Irland - engelsk - HPRA (Health Products Regulatory Authority)

athlone pharmaceuticals limited - paracetamol, tramadol hydrochloride - film coated tablet - 37.5/325 milligram - other opioids

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - tramadol hydrochloride, quantity: 37.5 mg; paracetamol, quantity: 325 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; macrogol 8000; hypromellose; hyprolose; stearic acid; titanium dioxide; croscarmellose sodium; iron oxide yellow; pregelatinised maize starch; povidone - tramadol/paracetamol is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.